| CR | PR | SD | PD | 总计 | ORR | DCR | PFS/月 |
Gefitinib | 0 | 7 | 9 | 10 | 26 | 26.9% | 61.5% | 9.5 |
Erlotinib | 0 | 9 | 10 | 7 | 26 | 34.6% | 73.0% | 10 |
Icotinib | 0 | 11 | 8 | 5 | 24 | 45.8% | 79.2% | 9.5 |